Table 3 |
|||||||
|
Relationship analysis among XIAP/Smac immunoscore, apoptosis index, and clinicopathologic variables |
|||||||
|
n* |
XIAP |
P value |
Smac |
P value |
AI |
P value |
|
|
|
|||||||
|
Age |
|||||||
|
<50 |
49 |
2.3 ± 0.8 |
0.5 ± 0.6 |
1.3 ± 1.0 |
|||
|
≥50 |
53 |
2.4 ± 0.8 |
0.586 |
0.3 ± 0.5 |
0.124 |
1.3 ± 1.1 |
0.903 |
|
Size |
|||||||
|
≤5 cm |
77 |
2.4 ± 0.8 |
0.4 ± 0.6 |
1.3 ± 1.1 |
|||
|
>5 cm |
25 |
2.2 ± 0.9 |
0.386 |
0.4 ± 0.7 |
0.880 |
1.4 ± 1.0 |
0.849 |
|
LN status |
|||||||
|
N0 |
39 |
2.4 ± 0.8 |
0.4 ± 0.6 |
1.2 ± 0.8 |
|||
|
N1-3 |
63 |
2.4 ± 0.8 |
0.969 |
0.4 ± 0.6 |
0.958 |
1.4 ± 1.2 |
0.282 |
|
Grade |
|||||||
|
I |
25 |
2.5 ± 0.7 |
0.5 ± 0.6 |
1.6 ± 1.4 |
|||
|
II-III |
77 |
2.3 ± 0.8 |
0.444 |
0.4 ± 0.6 |
0.555 |
1.2 ± 0.9 |
0.227 |
|
ER |
|||||||
|
positive |
39 |
2.3 ± 0.8 |
0.4 ± 0.6 |
1.2 ± 1.2 |
|||
|
negative |
63 |
2.4 ± 0.8 |
0.376 |
0.4 ± 0.6 |
0.659 |
1.4 ± 1.0 |
0.463 |
|
PR |
|||||||
|
positive |
44 |
2.3 ± 0.8 |
0.5 ± 0.6 |
1.3 ± 0.8 |
|||
|
negative |
58 |
2.4 ± 0.8 |
0.669 |
0.3 ± 0.6 |
0.319 |
1.4 ± 1.2 |
0.779 |
|
HER2 |
|||||||
|
positive |
94 |
2.4 ± 0.8 |
0.4 ± 0.6 |
1.3 ± 0.9 |
|||
|
negative |
8 |
2.2 ± 0.8 |
0.544 |
0.0 ± 0.6 |
<0.0001 |
1.8 ± 2.1 |
0.611 |
|
XIAP-N |
|||||||
|
positive |
44 |
2.6 ± 0.6 |
0.4 ± 0.6 |
1.3 ± 1.1 |
|||
|
negative |
58 |
2.2 ± 0.9 |
0.047 |
0.3 ± 0.6 |
0.540 |
1.4 ± 1.0 |
0.630 |
|
|
|||||||
|
n*: number of cases. AI: apoptosis index. LN: lymph node. XIAP-C and XIAP-N denoted cytoplasmic immune staining score and nuclear labeling of XIAP, respectively. P-values (two sided) < 0.05 were highlighted in bold. |
|||||||
|
Zhang et al. Diagnostic Pathology 2011 6:49 doi:10.1186/1746-1596-6-49 |
|||||||